Showing results (61-70 of 428) with videos related to
Sort By:
Pageof 43
Journal of Neuroimmunology|January 16, 2007
Neurodegeneration in autoimmune demyelination: recent mechanistic insights reveal novel therapeutic targetsOrhan Aktas, Sonia Waiczies, Frauke ZippCellular and Molecular Life Sciences : CMLS|March 14, 2016
Dendritic cells as therapeutic targets in neuroinflammationFelix Luessi, Frauke Zipp, Esther WitschFrontiers in Immunology|February 17, 2025
Biomarker combinations from different modalities predict early disability accumulation in multiple sclerosisVinzenz Fleischer, Tobias Brummer, Muthuraman Muthuraman, et al.Expert Review of Neurotherapeutics|October 22, 2014
Remyelinating strategies in multiple sclerosisFelix Luessi, Tanja Kuhlmann, Frauke ZippJAMA Neurology|October 23, 2013
Identification of inflammatory neuronal injury and prevention of neuronal damage in multiple sclerosis: hope for novel therapies?Frauke Zipp, Ralf Gold, Heinz WiendlScience Signaling|March 28, 2008
Geranylgeranylation but not GTP-loading of Rho GTPases determines T cell functionSonia Waiczies, Ivo Bendix, Frauke ZippTherapeutic Advances in Neurological Disorders|June 9, 2021
Serum neurofilament levels reflect outer retinal layer changes in multiple sclerosisCaspar B Seitz, Falk Steffen, Muthuraman Muthuraman, et al.Results and Problems in Cell Differentiation|October 31, 2006
Cell-cell communication by endocannabinoids during immune surveillance of the central nervous systemOliver Ullrich, Regine Schneider-Stock, Frauke ZippJournal of the Neurological Sciences|August 19, 2008
Therapeutic targeting of chemokine signaling in Multiple SclerosisIsabell Hamann, Frauke Zipp, Carmen Infante-DuarteJournal of Molecular Medicine (Berlin, Germany)|May 19, 2009
Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in central nervous system inflammationOlaf Hoffmann, Frauke Zipp, Joerg R WeberPageof 43